Merck & Co., Inc. (MRK)
99.01
+1.39
(+1.42%)
USD |
NYSE |
Dec 11, 16:00
99.74
+0.73
(+0.74%)
Pre-Market: 08:49
Merck EPS Diluted (TTM): 7.560 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Amgen, Inc. | 12.94 |
| Biogen, Inc. | 10.97 |
| Regeneron Pharmaceuticals, Inc. | 41.77 |
| Cidara Therapeutics, Inc. | -11.78 |
| Moderna, Inc. | -8.064 |